Study Of Exenatide Treatment Showed Improved Beta-Cell Function

Amylin Pharmaceuticals, Eli Lilly and Company announced study results comparing treatment of exenatide injection with insulin glargine on beta-cell function, glycemic control and weight in people with type 2 diabetes.

A new analysis of studies suggests cholesterol lowering drugs known as statins may not be as effective for preventing heart attack and stroke as we have been lead to believe. According to an expert review, the drugs do lower cholesterol. But claims about how well the drugs prevent heart disease have been exaggerated.